These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19753545)

  • 1. [Obesity and the relationship between somatotrophic axis and bone tissue].
    Ostrowska Z; Kobielski A; Kos-Kudła B; Marek B; Kajdaniuk D
    Endokrynol Pol; 2009; 60(4):302-9. PubMed ID: 19753545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Menopause, obesity, and bone status].
    Ostrowska Z
    Postepy Hig Med Dosw (Online); 2009 Feb; 63():39-46. PubMed ID: 19252463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kB ligand in postmenopausal obese women.
    Ostrowska Z; Świętochowska E; Marek B; Kajdaniuk D; Tyrpień-Golder K; Wołkowska-Pokrywa K; Damasiewicz-Bodzek A; Kos-Kudła B
    Endokrynol Pol; 2014; 65(6):438-48. PubMed ID: 25554611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reduction of bone mineral density in postmenopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH secretion impairment.
    Cecconi E; Gasperi M; Genovesi M; Bogazzi F; Grasso L; Cetani F; Procopio M; Marcocci C; Bartalena L; Martino E
    Eur J Endocrinol; 2006 Jul; 155(1):41-5. PubMed ID: 16793948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aging and estradiol supplementation on GH axis dynamics in women.
    Lieman HJ; Adel TE; Forst C; von Hagen S; Santoro N
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3918-23. PubMed ID: 11502833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between adiponectin, leptin, insulin growth factor-1 and bone mineral density in pre and postmenopausal women.
    Morcov C; Vulpoi C; Brănişteanu D
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):785-9. PubMed ID: 23272528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
    Gleeson HK; Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.
    Franco C; Brandberg J; Lönn L; Andersson B; Bengtsson BA; Johannsson G
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1466-74. PubMed ID: 15598680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs.
    Seck T; Scheppach B; Scharla S; Diel I; Blum WF; Bismar H; Schmid G; Krempien B; Ziegler R; Pfeilschifter J
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2331-7. PubMed ID: 9661604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complex relationship between obesity and the somatropic axis: the long and winding road.
    Savastano S; Di Somma C; Barrea L; Colao A
    Growth Horm IGF Res; 2014 Dec; 24(6):221-6. PubMed ID: 25315226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.
    Milliken LA; Going SB; Houtkooper LB; Flint-Wagner HG; Figueroa A; Metcalfe LL; Blew RM; Sharp SC; Lohman TG
    Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.
    Shen CL; Zhu W; Gao W; Wang S; Chen L; Chyu MC
    Nutr Res; 2013 Aug; 33(8):668-76. PubMed ID: 23890357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH/IGF-I and bone resorption in vivo and in vitro.
    Ueland T
    Eur J Endocrinol; 2005 Mar; 152(3):327-32. PubMed ID: 15757846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the selective estrogen receptor modulator, raloxifene, on the somatotropic axis and insulin-glucose homeostasis.
    Oleksik AM; Duong T; Pliester N; Asma G; Popp-Snijders C; Lips P
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2763-8. PubMed ID: 11397884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
    Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
    Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bone-adipose axis in obesity and weight loss.
    Gómez-Ambrosi J; Rodríguez A; Catalán V; Frühbeck G
    Obes Surg; 2008 Sep; 18(9):1134-43. PubMed ID: 18563500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytokines of bone turnover in postmenopause and old age].
    Pratelli L; Cenni E; Granchi D; Tarabusi C; Ciapetti G; Pizzoferrato A
    Minerva Med; 1999 Apr; 90(4):101-9. PubMed ID: 10518955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, growth hormone and weight loss.
    Rasmussen MH
    Mol Cell Endocrinol; 2010 Mar; 316(2):147-53. PubMed ID: 19723558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women.
    Friedlander AL; Butterfield GE; Moynihan S; Grillo J; Pollack M; Holloway L; Friedman L; Yesavage J; Matthias D; Lee S; Marcus R; Hoffman AR
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1496-503. PubMed ID: 11297574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.